Page 2 - Glaxosmithkline
Glaxo gets ready for next pandemic after hiccups in Covid vaccine
Pharma giant is talking with the UK and other governments about building facilities to bring vaccine development onshore before the next crisis.
 "Glaxo gets ready for next pandemic after hiccups in Covid vaccine")
GSK, Sanofi begin new Covid-19 vaccine trial after setback last year
If the results are conclusive, the two drugmakers hope to see the vaccine approved by the fourth quarter after having initially targeted the first half of this year
 "GSK, Sanofi begin new Covid-19 vaccine trial after setback last year")
GlaxoSmithKline Pharmaceuticals reports net profit of Rs 157 cr in Q3
GlaxoSmithKline Pharmaceuticals on Friday said it has registered a consolidated net profit of Rs 156.51 crore for the third quarter ended December
 "GlaxoSmithKline Pharmaceuticals reports net profit of Rs 157 cr in Q3")
UnitedHealth Group names former Glaxo CEO Witty to lead company
UnitedHealth Group is promoting former GlaxoSmithKline leader Sir Andrew Witty to become the health insurance provider's next CEO immediately.
 "UnitedHealth Group names former Glaxo CEO Witty to lead company")
Sanofi, GSK to supply Covax with 200 million doses of coronavirus vaccine
Sanofi and GSK have signed a Statement of Intent with Gavi, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual Covid-19 vaccines.
 "Sanofi, GSK to supply Covax with 200 million doses of coronavirus vaccine")
Equity fund raising rises 88% to $32.7 bn in first 9 months of 2020
This is already a record year for amount mobilised through the equity capital markets (ECM), topping $31.2 billion raised during calendar 2007, according to financial data firm Refinitiv
 "Equity fund raising rises 88% to $32.7 bn in first 9 months of 2020")
GlaxoSmithKline CEO optimistic Covid-19 vaccine widely available in 2021
The group's most advanced project is with French partner Sanofi and the two have said they hope to get approval for their candidate next year
 "GlaxoSmithKline CEO optimistic Covid-19 vaccine widely available in 2021")
Covid-19 vaccine makers must deliver to US in time to get full payments
The Cambridge, Massachusetts, biotech's $1.5-billion deal pays out in full if its vaccine receives regulatory clearance by January 31, 2021
US inks $1.5 bn deal with Moderna for 100 mn doses of Covid-19 'vaccine'
The US government previously gave Moderna around $1 billion to fund its research efforts, bringing total US funding to around $2.5 billion
 "US inks $1.5 bn deal with Moderna for 100 mn doses of Covid-19 'vaccine'")
US FDA approves GlaxoSmithKline's experimental drug for blood cancer
Multiple myeloma is the second most common form of blood cancer in the US and is generally considered treatable, but not curable
 "US FDA approves GlaxoSmithKline's experimental drug for blood cancer")
US to pay Sanofi, GSK $2.1 bn for Covid-19 vaccine to cover 50 mn people
A Sanofi executive said the companies had not yet agreed with the US on a specific price for additional doses
 "US to pay Sanofi, GSK $2.1 bn for Covid-19 vaccine to cover 50 mn people")
US books 100 mn Covid-19 vaccine doses for $2.1 bn from GSK, Sanofi Pasteur
The US government has a further option for the supply of an additional 500 million doses longer term as part of its Operation Warp Speed programme
 "US books 100 mn Covid-19 vaccine doses for $2.1 bn from GSK, Sanofi Pasteur")
Sanofi lifts earnings view as Regeneron stake sale boosts second quarter
Sanofi is working on two of the more than 150 potential Covid-19 vaccines being developed across the world
 "Sanofi lifts earnings view as Regeneron stake sale boosts second quarter")
GlaxoSmithKline Pharma Q1 net profit declines 2.38 pc to Rs 111 cr
The company had posted a net profit of Rs113.54crore in the corresponding period previous fiscal
World Coronavirus Dispatch: WHO stops trials of HCQ, HIV cocktail
Glaxo, Sanofi near $624 mn vaccine deal, Mexico deaths top 30,000, uneven recovery for Arab world and other pandemic-related news across the globe
 "World Coronavirus Dispatch: WHO stops trials of HCQ, HIV cocktail")
GSK buys 10% stake of German biotech firm CureVac in $164-million deal
GSK and CureVac, backed by Bill Gates, will work on developing up to five so-called mRNA-based vaccines and monoclonal antibodies (mAbs) for infectious diseases, they said.
 "GSK buys 10% stake of German biotech firm CureVac in $164-million deal")
Covid-19 crisis: HUL hints at margin pressures, higher operating costs
"Distribution costs have significantly increased and there will be short-term pressure on margins," Sanjiv Mehta, chairman and managing director said.
 "Covid-19 crisis: HUL hints at margin pressures, higher operating costs")
Second-generation Covid-19 vaccines are built for impact over speed
Some of the world's most prolific and experienced vaccine developers -- Sanofi, GlaxoSmithKline and Merck & Co - are among at least 100 challengers trailing the leaders
 "Second-generation Covid-19 vaccines are built for impact over speed")
J&J to begin human trials of Covid-19 vaccine in second half of July
The company has already signed deals with the US government to create enough manufacturing capacity to produce more than 1 billion doses of its vaccine through 2021
 "J&J to begin human trials of Covid-19 vaccine in second half of July")
GlaxoSmithKline Q4 consolidated net profit declines 6% to Rs 138 cr
The company had posted a net profit of Rs 146.81 crore for the same period previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing.
 "GlaxoSmithKline Q4 consolidated net profit declines 6% to Rs 138 cr")
